🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
(Neo)adjuvant treatment approaches and outcomes...
Status
Active Not Recruiting
Location
Research Site
Start Date
2023-06-30
Trial ID
NCT05939128
Lung cancer (LC) is the tumor responsible for the highest mortality worldwi...
Status
Recruiting
Location
Research Site
Start Date
2023-07-28
Trial ID
NCT06068049
The overall goal of this exploratory proof-of-concept study is to determine...
Status
Completed
Location
Task Applied Science and Stellenbosch University
Start Date
2017-08-23
Trial ID
NCT03174184
The Personalized Discovery Process is the only program offering patients tr...
Status
Terminated
Location
Icahn School of Medicine at Mount Sinai
Start Date
2015-01
Trial ID
NCT02363647
Treatments Being Tested
A Phase 2 multi-center open-label basket trial of nab-sirolimus for adult a...
Status
Active Not Recruiting
Location
Alabama Oncology
Start Date
2022-02-15
Trial ID
NCT05103358
Treatments Being Tested
RATIONALE: Studying samples of DNA in the laboratory from women who are BRC...
Status
Unknown
Location
Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office
Start Date
2008-04
Trial ID
NCT00897455
MGT005 is a natural history study to collect longitudinal prospective data ...
Status
Completed
Location
Kellogg Eye Center
Start Date
2016-04
Trial ID
NCT02714816
The management of cancers and their therapeutic guidance was until shortly ...
Status
Completed
Location
CGFL
Start Date
2016-05-15
Trial ID
NCT02840604
RATIONALE: Imatinib mesylate may stop the growth of cancer cells by blockin...
Status
Completed
Location
Roswell Park Cancer Institute
Start Date
2008-10
Trial ID
NCT00509093
This is a single-center, open-label, phase I clinical trial aimed to evalua...
Status
Unknown
Location
Tianjin Medical University Cancer Institute and Hospital
Start Date
2021-08-01
Trial ID
NCT05507606
Treatments Being Tested